$IQST
iQSTEL Inc Stock $iqst

$iqst Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000166357724000133 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$78.64M	$51.41M	$24.67M
YoY Change	139.56%	108.44%	27.02%
Cost Of Revenue	$76.47M	$50.04M	$23.45M
YoY Change	138.67%	113.37%	23.84%
Gross Profit	$2.164M	$1.379M	$1.217M
YoY Change	175.81%	13.34%	151.36%
Gross Profit Margin	2.75%	2.68%	4.93%
Selling, General & Admin	$2.352M	$1.495M	$1.440M
YoY Change	146.83%	3.85%	59.95%
% of Gross Profit	108.73%	108.42%	118.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.78K	$35.16K	$34.06K
YoY Change	-1.89%	3.23%	1.52%
% of Gross Profit	1.56%	2.55%	2.8%
Operating Expenses	$2.506M	$1.562M	$1.534M
YoY Change	141.59%	1.84%	56.75%
Operating Profit	-$342.1K	-$183.5K	-$317.5K
YoY Change	35.37%	-42.23%	-35.82%
Interest Expense	-$1.612M	-$365.5K	$192.7K
YoY Change	-1377.32%	-289.7%	-1393.89%
% of Operating Profit
Other Income/Expense, Net	-$1.557M	-$396.8K	$158.7K
YoY Change	-1809.06%	-350.0%	-3698.82%
Pretax Income	-$1.899M	-$580.2K	-$158.8K
YoY Change	1074.56%	265.32%	-69.73%
Income Tax	$65.28K
% Of Pretax Income
Net Earnings	-$1.964M	-$580.2K	-$363.2K
YoY Change	817.94%	59.76%	-34.56%
Net Earnings / Revenue	-2.5%	-1.13%	-1.47%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	176.8M shares	176.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$797.2K	$2.726M	$1.777M
YoY Change	-29.25%	53.36%	-57.96%
Cash & Equivalents	$797.2K	$2.726M	$1.777M
Short-Term Investments
Other Short-Term Assets	$1.307M	$1.500M	$50.86K
YoY Change	3628.94%	2849.27%	-63.96%
Inventory	$26.94K	$26.94K	$26.12K
Prepaid Expenses	$1.969M	$1.975M	$563.2K
Receivables	$13.77M	$9.000M	$3.970M
Other Receivables	$1.324M	$1.025M	$913.3K
Total Short-Term Assets	$17.22M	$15.62M	$6.737M
YoY Change	142.62%	131.85%	-8.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$583.3K	$559.5K	$433.1K
YoY Change	23.18%	29.18%	8.58%
Goodwill	$10.68M	$5.172M	$5.172M
YoY Change	106.43%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$979.7K	$241.0K	$445.1K
YoY Change	1698.63%	-45.85%	0.86%
Total Long-Term Assets	$12.77M	$6.499M	$6.150M
YoY Change	104.12%	5.68%	148.23%
TOTAL ASSETS
Total Short-Term Assets	$17.22M	$15.62M	$6.737M
Total Long-Term Assets	$12.77M	$6.499M	$6.150M
Total Assets	$29.99M	$22.12M	$12.89M
YoY Change	124.58%	71.64%	30.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.507M	$1.615M	$2.270M
YoY Change	177.83%	-28.88%	49.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$3.555M	$3.469M	$0.00
YoY Change	1302.48%
Long-Term Debt Due	$2.545M	$103.7K	$95.41K
YoY Change	913.03%	8.73%	-71.61%
Total Short-Term Liabilities	$22.20M	$13.48M	$6.301M
YoY Change	221.17%	114.01%	137.81%
LONG-TERM LIABILITIES
Long-Term Debt		$90.21K	$100.3K
YoY Change		-10.02%	-7.55%
Other Long-Term Liabilities	$214.1K	$169.7K	$156.0K
YoY Change	34.39%	8.82%	0.86%
Total Long-Term Liabilities	$214.1K	$260.0K	$256.2K
YoY Change	-18.19%	1.45%	-2.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.20M	$13.48M	$6.301M
Total Long-Term Liabilities	$214.1K	$260.0K	$256.2K
Total Liabilities	$22.41M	$13.74M	$6.557M
YoY Change	212.43%	109.61%	236.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.90M	-$26.89M	-$24.87M
YoY Change	15.23%	8.15%
Common Stock	$179.6K	$177.6K	$164.6K
YoY Change	9.05%	7.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.572M	$8.374M	$7.049M
YoY Change
Total Liabilities & Shareholders Equity	$29.99M	$22.12M	$12.89M
YoY Change	124.58%	71.64%	30.84%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.964M	-$580.2K	-$363.2K
YoY Change	817.94%	59.76%	-34.56%
Depreciation, Depletion And Amortization	$33.78K	$35.16K	$34.06K
YoY Change	-1.89%	3.23%	1.52%
Cash From Operating Activities	-$2.615M	-$536.9K	$197.2K
YoY Change	184.66%	-372.31%	-144.04%
INVESTING ACTIVITIES
Capital Expenditures	$31.81K	$71.66K	$63.25K
YoY Change	-53.9%	13.3%	-353.8%
Acquisitions
YoY Change
Other Investing Activities	-$1.065M	-$1.551M	-$79.70K
YoY Change	1486.97%	1846.34%
Cash From Investing Activities	-$1.097M	-$1.623M	-$142.9K
YoY Change	706.02%	1035.31%	473.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.784M	$3.523M	$391.0K
YoY Change	345.94%	800.96%	-71.42%
NET CHANGE
Cash From Operating Activities	-2.615M	-$536.9K	$197.2K
Cash From Investing Activities	-1.097M	-$1.623M	-$142.9K
Cash From Financing Activities	1.784M	$3.523M	$391.0K
Net Change In Cash	-1.928M	$1.363M	$447.8K
YoY Change	194.54%	204.33%	-49.99%
FREE CASH FLOW
Cash From Operating Activities	-$2.615M	-$536.9K	$197.2K
Capital Expenditures	$31.81K	$71.66K	$63.25K
Free Cash Flow	-$2.647M	-$608.6K	$133.9K
YoY Change	167.99%	-554.43%	-131.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2024Q1	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1		usd
CY2023Q1	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2024Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2023Q1	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2024Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets		usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2023Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2024Q1	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties		usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes		usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2024Q1	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1500000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1975266	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1449094	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	15619755	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	15719172	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	559497	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522997	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2024Q1	us-gaap	Goodwill Goodwill	5172146	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5172146	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	426755	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	426755	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	241025	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	214991	usd
CY2024Q1	us-gaap	Assets Assets	22118770	usd
CY2023Q4	us-gaap	Assets Assets	22155653	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1614500	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2966279	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8010927	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9993585	usd
CY2024Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3750	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	103738	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	264988	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	923185	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	39012	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3469435	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13484660	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13840944	usd
CY2024Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	90214	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	99099	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	169738	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	169738	usd
CY2024Q1	us-gaap	Liabilities Liabilities	13744612	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14109781	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	177584984	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	177584984	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172129630	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172129630	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	177585	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	172130	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35263931	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34360884	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26893900	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26084133	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25340	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25340	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8522317	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8423582	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	148159	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	377710	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8374158	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8045872	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22118770	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22155653	usd
CY2024Q1	us-gaap	Revenues Revenues	51414878	usd
CY2023Q1	us-gaap	Revenues Revenues	24666529	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	50035852	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	23449793	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1379026	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1216736	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1562478	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1534266	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1562478	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1534266	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183452	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-317530	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	71777	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-407	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-33954	usd
CY2024Q1	IQST	Interest Expense2 InterestExpense2	365474	usd
CY2023Q1	IQST	Interest Expense2 InterestExpense2	3645	usd
CY2023Q1	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	196307	usd
CY2024Q1	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-102660	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-396764	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	158708	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-580216	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-158822	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-580216	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-158822	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	229551	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	204363	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-809767	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-363185	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-580216	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-158822	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	-1577	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-580216	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-157245	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	229551	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	205136	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-809767	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-362381	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q1	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	175152920	shares
CY2023Q1	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	164034479	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8045872	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31065	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	279660	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	597777	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-580216	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8374158	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5835417	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11230	usd
CY2023Q1	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	240258	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	1577	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-158822	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6329660	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-580216	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-158822	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	31065	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11230	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	725	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35161	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34060	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	207742	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-196307	usd
CY2024Q1	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-102660	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2743089	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-564365	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	185	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	552204	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16204	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-5131	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-556055	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	537667	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1969040	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-583957	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-536888	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	197163	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	-1500000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71662	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63247	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	-80000	usd
CY2024Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	51230	usd
CY2023Q1	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	300	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1622892	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-142947	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	8885	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	9006	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	400000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	3722500	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-190932	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3522683	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	390994	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2627	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1362903	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	447837	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1362668	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1329389	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2725571	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1777226	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	89578	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	279660	usd
CY2023Q1	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	240258	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	597777	usd
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2011-06-24
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	357500	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	133207	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	20000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1975266	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1449094	usd
CY2024Q1	us-gaap	Reclassifications Reclassifications	<p id="xdx_84D_eus-gaap--Reclassifications_zMeRet0yrIQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><i>Reclassification</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zUOQYzIUjo32" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The preparation of the consolidated financial statements in conformity with GAAP in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	725	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	115922	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	312116	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1320870	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	738050	usd
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	21000	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	21000	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	26767	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	428	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	357500	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1386671	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1323432	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	-827174	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	-800435	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	559497	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522997	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35161	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34060	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	193952	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	367837	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	193952	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	364087	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	103738	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	264988	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	90214	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	99099	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	8885	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	9006	usd
CY2024Q1	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-102660	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	259447	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	259447	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4392620	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	369044	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3469435	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3469435	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5455354	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	177584984	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	177584984	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172129630	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172129630	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	391745	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	340515	usd
CY2024Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	211500	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	144000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	31065	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11230	usd
CY2024Q1	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	137127	usd
CY2023Q4	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	100128	usd
CY2024Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7122	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	900	usd
CY2024Q1	us-gaap	Revenues Revenues	51414878	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	50035852	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1379026	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1562478	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183452	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-396764	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-580216	usd
CY2023Q1	us-gaap	Revenues Revenues	24666529	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	23449793	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1216736	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1534266	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-317530	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	158708	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-158822	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	15619755	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	6499015	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13484660	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	259952	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	15719172	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	6436481	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13840944	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	268837	usd

Files In Submission

Name	View Source	Status
0001663577-24-000133-index-headers.html	Edgar Link	pending
0001663577-24-000133-index.html	Edgar Link	pending
0001663577-24-000133.txt	Edgar Link	pending
0001663577-24-000133-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
iqst-20240331.xsd	Edgar Link	pending
iqst10q_033134.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
iqst-20240331_lab.xml	Edgar Link	unprocessable
iqst-20240331_pre.xml	Edgar Link	unprocessable
iqst10q_033134_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
iqst-20240331_def.xml	Edgar Link	unprocessable
iqst-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IQST
iQSTEL Inc Stock $iqst

2024 Q2 Form 10-Q Financial Statement

#000166357724000133 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST iQSTEL Inc Stock $iqst

2024 Q2 Form 10-Q Financial Statement

#000166357724000133 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST
iQSTEL Inc Stock $iqst